Skip to main content

United Health Products Inc(UEEC)
OTC US

Today's Change
Delayed Last Update
Day Low0.0694
Day High0.0800
Open:0.0782
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
United Health Products Provides Regulatory Update
United Health Products Secures New Convertible and Equity Financing
United Health Products Provides Corporate Update
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th
Life Science Virtual Investor Forum Agenda Announced for September 18th
United Health Products Provides Regulatory Status Update
United Health Products Provides Regulatory Application Update
United Health Products Announces OTCQB Uplisting and FDA Update
United Health Products Provides Update on Capital Markets and Regulatory Processes
United Health Products Provides Update on FDA PMA Application Process
United Health Products Submits Full FDA PMA Application
Why this money manager is steering clear of Canadian stocks and adding U.S. banks and tech
United Health Products Announces Settlement of SEC Investigation
United Health Products Provides Regulatory Update

Profile

United Health Products, Inc. develop, manufactures and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudate/drainage from superficial wounds and control bleeding. It serves dental and medical markets. United Health Products, Inc. is based in Henderson, Nevada.